Benign Growth For Regal Holding Co., Ltd. Underpins Stocks 36 percent Plummet

RGC Stock  USD 5.45  0.07  1.27%   
About 62% of Regencell Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Regencell Bioscience Holdings suggests that many traders are alarmed. The current market sentiment, together with Regencell Bioscience's historical and current headlines, can help investors time the market. In addition, many technical investors use Regencell Bioscience stock news signals to limit their universe of possible portfolio assets.
  
Regal Holding Co., Ltd. shares have had a horrible month, losing 36 percent after a relatively good period...

Read at simplywall.st
Simply Wall St News at Macroaxis
  

Regencell Bioscience Fundamental Analysis

We analyze Regencell Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Regencell Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Regencell Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Number Of Shares Shorted

Number Of Shares Shorted Comparative Analysis

Regencell Bioscience is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.

Regencell Bioscience Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Regencell Bioscience stock to make a market-neutral strategy. Peer analysis of Regencell Bioscience could also be used in its relative valuation, which is a method of valuing Regencell Bioscience by comparing valuation metrics with similar companies.

Complementary Tools for Regencell Stock analysis

When running Regencell Bioscience's price analysis, check to measure Regencell Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regencell Bioscience is operating at the current time. Most of Regencell Bioscience's value examination focuses on studying past and present price action to predict the probability of Regencell Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regencell Bioscience's price. Additionally, you may evaluate how the addition of Regencell Bioscience to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals